Phase II study of alternating chemotherapy regimens for advanced non-small cell lung cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference63 articles.
1. Non-small cell lung cancer collaborative group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995;311:899–909.
2. Randomized study vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients;Le Chevalier;J. Clin. Oncol.,1994
3. Comparison of survival and quality of life in advanced non-small cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial;Bonomi;J. Clin. Oncol.,2000
4. Randomized phase III trial comparing cisplatin/etoposide versus carboplatin/paclitaxel in advanced and metastatic non-small cell lung cancer;Belani;Proc. Annu. Meet Am. Soc. Clin. Oncol.,1998
5. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N Eng. J. Med.,2002
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Identification of prognostic biomarkers for major subtypes of non-small-cell lung cancer using genomic and clinical data;Journal of Cancer Research and Clinical Oncology;2020-07-14
2. MicroRNA‐125a attenuates the chemoresistance against ubenimex in non–small cell lung carcinoma via targeting the aminopeptidase N signaling pathway;Journal of Cellular Biochemistry;2019-10-08
3. Genetic variation in the DNA repair pathway as a potential determinant of response to platinum-based chemotherapy in breast cancer;Journal of Cellular Physiology;2017-08-30
4. Chemoresistance factors in non-small cell lung cancer;Pathologia;2016-06-23
5. Examining the relationship between fatigue and cognition after stroke: A systematic review;Neuropsychological Rehabilitation;2016-01-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3